MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nefro.2015.10.017

Медицинская библиотека · Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia · 2016

Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure.

Orellana José M, Esteban Rafael J, Castilla Yina A, Fernández-Castillo Rafael, Nozal-Fernández Gonzalo, Esteban María A, García-Valverde María, Bravo Juan

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidism (SHPT) have been described in patients on dialysis.

OBJECTIVES

To evaluate the efficacy and safety of cinacalcet in SHPT not on dialysis and its effects on bone turnover markers.

METHODS

Non-randomised, longitudinal, observational, analytical study of patients with chronic kidney disease (CKD) and SHPT (PTH> 80 pg/mL) as well as normo- or hypercalcaemia (≥8.5mg/dL), treated with cinacalcet.

RESULTS

Mean cinacalcet dose was 30mg/day in 66.7%. We studied 15 patients (10 women), aged 66.0±17.93years. The aetiology was unknown in 20% of cases. Sociodemographic variables and renal function parameters were recorded. We compared values at baseline as well as after 6 and 12 months. Calcium (10.3±0.55 vs. 9.4±1.04) and iPTH (392.4±317.65 vs. 141.8±59.26) levels decreased. Increased levels of phosphorus (3.7±1.06 vs. 3.9±0.85) and ß-CTX (884.2±797.22 vs. 1053.6±999.00) were detected, although there were no significant changes in GFR, urinary calcium or other bone markers. Two patients withdrew from the study (gastrointestinal intolerance and parathyroidectomy, respectively).

CONCLUSIONS

Cinacalcet at low doses is effective in the management of SHPT in CKD patients who are not on dialysis. Its use reduces iPTH and calcaemia, without causing serious side effects or significant changes in renal function.

Для цитирования: Orellana José M, Esteban Rafael J, Castilla Yina A, Fernández-Castillo Rafael, Nozal-Fernández Gonzalo, Esteban María A, García-Valverde María, Bravo Juan. Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure.. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2016. DOI: 10.1016/j.nefro.2015.10.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.